{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:20:51Z","timestamp":1783149651065,"version":"3.54.6"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2026-RISE-10-005"],"award-info":[{"award-number":["2026-RISE-10-005"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["NRF- 2023R1A2C100505811"],"award-info":[{"award-number":["NRF- 2023R1A2C100505811"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.neuropharm.2026.111028","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T15:34:07Z","timestamp":1779464047000},"page":"111028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Neuroprotective effects of serum- and glucocorticoid-regulated kinase 1 protein in a Parkinson's disease model"],"prefix":"10.1016","volume":"297","author":[{"given":"Min Hyung","family":"Seo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4240-4677","authenticated-orcid":false,"given":"Sun-Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0585-1213","authenticated-orcid":false,"given":"Soo-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9883-6153","authenticated-orcid":false,"given":"Sujung","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.111028_bib1","doi-asserted-by":"crossref","first-page":"8708","DOI":"10.1073\/pnas.1300886110","article-title":"Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis","volume":"110","author":"Anacker","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2026.111028_bib2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2026.111028_bib3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00109-006-0082-0","article-title":"Blunted DOCA\/high salt induced albuminuria and renal tubulointerstitial damage in gene-targeted mice lacking SGK1","volume":"84","author":"Artunc","year":"2006","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.neuropharm.2026.111028_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000214439","article-title":"Responses to diuretic treatment in gene-targeted mice lacking serum- and glucocorticoid-inducible kinase 1","volume":"32","author":"Artunc","year":"2009","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.neuropharm.2026.111028_bib5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00439-009-0673-2","article-title":"Novel mutations affecting the Na, K ATPase alpha model complex neurological diseases and implicate the sodium pump in increased longevity","volume":"126","author":"Ashmore","year":"2009","journal-title":"Hum. Genet."},{"key":"10.1016\/j.neuropharm.2026.111028_bib6","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1038\/s41388-022-02479-4","article-title":"Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatment","volume":"41","author":"Battaglin","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.neuropharm.2026.111028_bib7","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1471-4159.2006.03629.x","article-title":"Post-translational regulation of EAAT2 function by co-expressed ubiquitin ligase Nedd4-2 is impacted by SGK kinases","volume":"97","author":"Boehmer","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.111028_bib8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0962-8924(98)01251-3","article-title":"Control of cell proliferation by Myc","volume":"8","author":"Bouchard","year":"1998","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.neuropharm.2026.111028_bib9","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.1074\/jbc.274.11.7253","article-title":"Cell cycle and hormonal control of nuclear-cytoplasmic localization of the serum- and glucocorticoid-inducible protein kinase, Sgk, in mammary tumor cells. A novel convergence point of anti-proliferative and proliferative cell signaling pathways","volume":"274","author":"Buse","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.111028_bib10","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014357","article-title":"An overview of MYC and its interactome","volume":"4","author":"Conacci-Sorrell","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neuropharm.2026.111028_bib11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fnmol.2019.00299","article-title":"Targeting Alpha-Synuclein as a therapy for Parkinson's Disease","volume":"12","author":"Fields","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111028_bib12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00424-002-0873-2","article-title":"K+ channel activation by all three isoforms of serum- and glucocorticoid-dependent protein kinase SGK","volume":"445","author":"Gamper","year":"2002","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.neuropharm.2026.111028_bib13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02741387","article-title":"Tyrosine hydroxylase and Parkinson's disease","volume":"16","author":"Haavik","year":"1998","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111028_bib14","first-page":"679","article-title":"Parkinson disease","volume":"102","author":"Halli-Tierney","year":"2020","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.neuropharm.2026.111028_bib15","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0306-4522(97)00014-6","article-title":"Distribution of the messenger RNA for the extracellularly regulated kinases 1, 2 and 3 in rat brain: effects of excitotoxic hippocampal lesions","volume":"79","author":"Hollister","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.111028_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3389\/fphys.2016.00209","article-title":"Insights into the pathology of the alpha 3 Na(+)\/K(+)-ATPase ion pump in neurological disorders; lessons from animal models","volume":"7","author":"Holm","year":"2016","journal-title":"Front. Physiol."},{"key":"10.1016\/j.neuropharm.2026.111028_bib17","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1128\/MCB.01510-14","article-title":"Serum- and glucocorticoid-inducible kinase 1 confers protection in cell-based and in in vivo neurotoxin models via the c-Jun N-Terminal kinase signaling pathway","volume":"35","author":"Iqbal","year":"2015","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.neuropharm.2026.111028_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-5793(94)00395-5","article-title":"Identification of two distinct synucleins from human brain","volume":"345","author":"Jakes","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2026.111028_bib19","first-page":"6467","article-title":"The neurotransmitter gamma-aminobutyric acid is an inhibitory regulator for the migration of SW 480 colon carcinoma cells","volume":"62","author":"Joseph","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuropharm.2026.111028_bib20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jcmgh.2019.10.006","article-title":"Novel human NKCC1 mutations cause defects in goblet cell mucus secretion and chronic inflammation","volume":"9","author":"Koumangoye","year":"2020","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.neuropharm.2026.111028_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/09687688.2013.874598","article-title":"Regulation of transport across cell membranes by the serum- and glucocorticoid-inducible kinase SGK1","volume":"31","author":"Lang","year":"2014","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.neuropharm.2026.111028_bib22","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1021\/cn200074d","article-title":"Phosphorylation of alpha-Synuclein at Y125 and S129 alters its metal binding properties: implications for understanding the role of alpha-Synuclein in the pathogenesis of Parkinson's Disease and related disorders","volume":"2","author":"Lu","year":"2011","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111028_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/978-94-007-5416-4_16","article-title":"Parkinson's disease","volume":"65","author":"Mhyre","year":"2012","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.neuropharm.2026.111028_bib24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1263\/jbb.104.34","article-title":"Development of series of gateway binary vectors, pGWBs, for realizing efficient construction of fusion genes for plant transformation","volume":"104","author":"Nakagawa","year":"2007","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.neuropharm.2026.111028_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3233\/JPD-160779","article-title":"Implication of Alpha-Synuclein phosphorylation at S129 in synucleinopathies: what have we learned in the last decade?","volume":"6","author":"Oueslati","year":"2016","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neuropharm.2026.111028_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.0953-816X.2003.03131.x","article-title":"The serum- and glucocorticoid-induced kinase SGK inhibits mutant huntingtin-induced toxicity by phosphorylating serine 421 of huntingtin","volume":"19","author":"Rangone","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111028_bib27","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","article-title":"Parkinson's disease","volume":"363","author":"Samii","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2026.111028_bib28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1515\/revneuro-2012-0071","article-title":"The role of Ser129 phosphorylation of alpha-synuclein in neurodegeneration of Parkinson's disease: a review of in vivo models","volume":"24","author":"Sato","year":"2013","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111028_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.mcn.2005.07.017","article-title":"Sgk1, a cell survival response in neurodegenerative diseases","volume":"30","author":"Schoenebeck","year":"2005","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111028_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216408","article-title":"Association between decreased SGK1 and increased intestinal alpha-Synuclein in an MPTP mouse model of Parkinson's Disease","volume":"24","author":"Seo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111028_bib31","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00424-002-0823-z","article-title":"Stimulation of Xenopus oocyte Na(+),K(+)ATPase by the serum and glucocorticoid-dependent kinase sgk1","volume":"444","author":"Setiawan","year":"2002","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.neuropharm.2026.111028_bib32","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1460-9568.2005.03859.x","article-title":"sgk1, a member of an RNA cluster associated with cell death in a model of Parkinson's disease","volume":"21","author":"Stichel","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111028_bib33","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/gast.2001.24045","article-title":"Inhibition of Na+,K+-ATPase by interferon gamma down-regulates intestinal epithelial transport and barrier function","volume":"120","author":"Sugi","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2026.111028_bib34","first-page":"G223","article-title":"Neural reflexes controlling intestinal microcirculation","volume":"271","author":"Vanner","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2026.111028_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14175-5","article-title":"Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease","volume":"7","author":"Vicente Miranda","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.111028_bib36","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00424-001-0737-1","article-title":"Cerebral localization and regulation of the cell volume-sensitive serum- and glucocorticoid-dependent kinase SGK1","volume":"443","author":"Warntges","year":"2002","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.neuropharm.2026.111028_bib37","doi-asserted-by":"crossref","first-page":"11482","DOI":"10.1016\/S0021-9258(19)50221-6","article-title":"Immediate-early transcriptional regulation and rapid mRNA turnover of a putative serine\/threonine protein kinase","volume":"268","author":"Webster","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.111028_bib38","first-page":"2031","article-title":"Characterization of sgk, a novel member of the serine\/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum","volume":"13","author":"Webster","year":"1993","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.neuropharm.2026.111028_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-79171-8","article-title":"Modulation of serotonin signaling\/metabolism by Akkermansia muciniphila and its extracellular vesicles through the gut-brain axis in mice","volume":"10","author":"Yaghoubfar","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.111028_bib40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.gene.2018.03.086","article-title":"Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells","volume":"661","author":"Yeo","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.neuropharm.2026.111028_bib41","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.dld.2018.09.017","article-title":"The risk of Parkinson's disease in inflammatory bowel disease: a systematic review and meta-analysis","volume":"51","author":"Zhu","year":"2019","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.neuropharm.2026.111028_bib42","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4103\/1673-5374.317981","article-title":"Association between inflammatory bowel diseases and Parkinson's disease: systematic review and meta-analysis","volume":"17","author":"Zhu","year":"2022","journal-title":"Neural Regen. Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826002017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826002017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:03:34Z","timestamp":1783148614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826002017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":42,"alternative-id":["S0028390826002017"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111028","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective effects of serum- and glucocorticoid-regulated kinase 1 protein in a Parkinson's disease model","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111028"}}